Notably, FT enhanced theexpression of liver fatty acid β-oxidation proteins, such aspAMPK/AMPK, PPARα, and PGC-1α, suggesting its potentialto counter liver steatosis (Figure 3A–C). The gene discussed is PPARA; the disease is fatty liver disease.